Filter Results
:
(6,586)
Show Results For
-
All HBS Web
(6,586)
- People (25)
- News (1,966)
- Research (2,422)
- Events (32)
- Multimedia (146)
- Faculty Publications (1,284)
Show Results For
-
All HBS Web
(6,586)
- People (25)
- News (1,966)
- Research (2,422)
- Events (32)
- Multimedia (146)
- Faculty Publications (1,284)
- October 2017 (Revised July 2018)
- Case
Data Science at Target
By: Srikant M. Datar and Caitlin N. Bowler
Paritosh Desai joined Target.com in 2013 as VP of Business Intelligence, Analytics & Testing to explore how the retailer could use its relatively small but thriving e-commerce arm to drive sales and win customers. The case explores the technological and organizational...
View Details
Keywords:
Data Science;
Analytics and Data Science;
Organizational Change and Adaptation;
Competitive Strategy;
Problems and Challenges;
Innovation Leadership
Datar, Srikant M., and Caitlin N. Bowler. "Data Science at Target." Harvard Business School Case 118-016, October 2017. (Revised July 2018.)
- 13 Aug 2014
- News
Blavatnik Fellows in Life Science Entrepreneurship Named
- Web
MS/MBA Biotechnology: Life Sciences - MBA
MS/MBA Biotechnology: Life Sciences A joint degree that blends science, business & ethics A joint degree with the Graduate School of Arts and Sciences. Students are affiliated...
View Details
- January 2014 (Revised December 2014)
- Case
GenapSys: Business Models for the Genome
By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble
GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details
Keywords:
DNA Sequencing;
Life Sciences;
Business Model;
Innovation & Entrepreneurship;
Health Care and Treatment;
Genetics;
Business Strategy;
Biotechnology Industry;
Pharmaceutical Industry;
Technology Industry;
Health Industry;
Medical Devices and Supplies Industry;
United States
Hamermesh, Richard G., Joseph B. Fuller, and Matthew Preble. "GenapSys: Business Models for the Genome." Harvard Business School Case 814-050, January 2014. (Revised December 2014.)
- 13 Aug 2019
- Blog Post
What is the MS/MBA Biotechnology: Life Sciences Program?
MS/MBA Biotechnology: Life Sciences Webinar Discover the new MS/MBA Biotechnology: Life Sciences Program, the two-year joint degree that blends...
View Details
- 01 Aug 2019
MS/MBA Biotechnology: Life Sciences Webinar
- Research Summary
National Innovation Systems in the Life Sciences
This is an international comparative study of how institutional contexts shape the process by which science is leveraged into commercial technology. The study explores how variance in corporate governance systems, knowledge- and skill-formation systems, and...
View Details
- TeachingInterests
Data Science for Managers
By: Chiara Farronato
This new course is taught as a required course in the first year MBA curriculum as of a.y. 2023-2024. It provides students with the foundations of data science to become effective data-driven managers. The course covers the basics of visualization, statistical and...
View Details
- 24 Aug 2017
- Video
Building Businesses around Breakthrough Science
- 05 Oct 2016
- News
Harvard to Open Life Sciences Lab
possible by a gift from Judy (MBA 1983) and Steve Pagliuca (MBA 1982), the lab will offer shared space for high-potential life sciences and biotech startups that are founded by Harvard faculty, alumni,...
View Details
- 18 Jul 2023
Harvard MS/MBA Biotechnology: Life Sciences Q&A
Join alumni and current students for a virtual Q&A on Harvard's two-year MS/MBA Biotechnology: Life Sciences Program. Get all your program and admissions questions answered.
View Details
- 17 Oct 2019
MS/MBA Biotechnology: Life Sciences Event
Join us for an event at Evelo Biosciences to learn more about Harvard's new MS/MBA Biotechnology: Life Sciences joint degree.
View Details
- December 1998 (Revised September 1999)
- Case
Novartis: Betting on Life Sciences
By: Ray A. Goldberg, Carin-Isabel Knoop and Srinivas Sunder
The merger of Ciba-Geigy and Sandoz produced genomic-based synergies for health care, agribusiness, and nutritional supplements. How to build on the strength of the individual divisions and provide synergies that would continue Novartis' leadership role is the question...
View Details
Keywords:
Mergers and Acquisitions;
Business Divisions;
Health Care and Treatment;
Leadership;
Product Positioning;
Science-Based Business;
Corporate Strategy;
Pharmaceutical Industry
Goldberg, Ray A., Carin-Isabel Knoop, and Srinivas Sunder. "Novartis: Betting on Life Sciences." Harvard Business School Case 599-076, December 1998. (Revised September 1999.)
- 11 Jul 2023
MS/MBA Biotechnology: Life Sciences Information Session
Join us for a virtual event with program faculty and Admissions staff to learn more about Harvard's MS/MBA Biotechnology: Life Sciences joint degree.
View Details
- 11 Jun 2018
- Blog Post
Meet the 2018-2019 Blavatnik Fellows in Life Science Entrepreneurship
entrepreneurs giving them the foundation needed to achieve their goals. Among those resources is the Blavatnik Fellows in Life Science Entrepreneurship. Meet the 2018-2019 Blavatnik Fellows This innovative...
View Details